Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "Outperformers"


6 mentions found


It has not been a good year for the S & P 500 . But one index is beating the S & P 500, according to investment veteran Jeffrey Kleintop — and it's not one you might expect. The MSCI United Kingdom Index, which includes large and mid-cap U.K. stocks, is down about 5% and 22% this year, in sterling and dollar terms respectively, according to Eikon data. "Analysts' consensus S & P 500 EPS estimate for 2022, at about $224, has been declining since June. Kleintop noted that a key reason for U.K earnings strength is the British pound's weakness against the U.S. dollar this year.
This is the daily notebook of Mike Santoli, CNBC's senior markets commentator, with ideas about trends, stocks and market statistics. This could simply be a matter of short-term oversold conditions, a pause in the bond-yield surge and general hesitation ahead of a crucial-seeming CPI report Thursday. There's some focus on the S & P 500's 200-week (1,000-day) moving average offering an excuse for some support here, as it did at the end of 2018. Forecasts have come in a lot (S & P 500 consensus down 7 percentage points ex-energy since July), but it's unclear if that's enough. VIX is sticky in the low-30s, a pretty agitated state, and likely will stay inflated into/through Thursday's CPI report.
Check out the companies making the biggest moves midday:Hertz — Shares of the rental rental company jumped 1.9% after the company announced a partnership with BP's electric vehicle charging unit that will put thousands of charging stations at Hertz locations. Many of the stations will be used to charge Hertz's growing fleet of electric vehicles, but some will be available for public use. Keurig Dr Pepper — The beverage company shed about 3% after being downgraded by Goldman Sachs to a neutral rating from a buy. Lucid — The electric vehicle stock climbed 1.4% on Tuesday after Cantor Fitzgerald initiated coverage of Lucid with an overweight rating. Ark Invest's Cathie Wood also told CNBC Tuesday she is sticking by her bullish call on Tesla, saying "our confidence couldn't be higher as we see the movement towards electric vehicles accelerates."
Change Healthcare – Shares of Change Healthcare jumped 6.4% after a federal judge said that UnitedHealth cannot take over the company. Humana – Shares of health company Humana gained 1% and touched an all-time high a day after the company raised its earnings guidance for the fiscal year. Cognex — Shares of machine vision systems maker Cognex jumped nearly 7% after the company raised its revenue outlook for the current quarter. Olin — The manufacturing company fell 4.6% after issuing its third-quarter EBITDA guidance. MicroStrategy – Shares of software company MicroStrategy fell 4.6% after the company announced that it made its smallest purchase of Bitcoin in two years.
James Abate expects that his fund distinguished itself this year by maintaining a traditional bottom-up perspective on stocks. The flagship fund of Cathie Wood's ARK Invest, the ARK Innovation ETF , is down 28% this year. The fund manager maintains a concentrated portfolio of 35 to 50 of his best ideas. The fund manager also incorporates hedging techniques, specifically put options, from time to time to fortress the portfolio during periods of volatility, such as during the pandemic. Before founding Centre Asset Management in 2006, Abate started his career as a manager of valuation services at PriceWaterhouseCoopers in 1987, according to LinkedIn.
Stocks were hurling toward a big losing week on Friday as investors weighed a warning from FedEx as well as a hot inflation reading. The S & P 500 is 5.3% lower this week, on pace for its fourth losing week in five. APA Corp . was the top S & P 500 stock this week after advancing 6.1% as of 9:40 a.m, ET. On Monday, the energy stock was upgraded to buy from neutral by Citi, which said APA is an "under-appreciated growth story." However, there isn't a consensus in favor of buying the stock, with only 45% of analysts rating it a buy.
Total: 6